MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517057624 A) filed by Polygon Therapeutics, Levallois-Perret, France, on June 16, for 'anti-cd8 alpha depleting antibodies.'
Inventor(s) include Monseur, Tatiana; and Abou Ali, Mohamed.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel anti-CD8a (cluster of differentiation 8 alpha) antibodies and antigen-binding fragments thereof, and to therapeutic uses thereof."
The patent application was internationally filed on Nov. 17, 2023, under International application No.PCT/EP2023/082168.
Disclaimer: Curated by HT Syndication.
